RU2015110054A - Мультимаркерная стратификация риска - Google Patents
Мультимаркерная стратификация риска Download PDFInfo
- Publication number
- RU2015110054A RU2015110054A RU2015110054A RU2015110054A RU2015110054A RU 2015110054 A RU2015110054 A RU 2015110054A RU 2015110054 A RU2015110054 A RU 2015110054A RU 2015110054 A RU2015110054 A RU 2015110054A RU 2015110054 A RU2015110054 A RU 2015110054A
- Authority
- RU
- Russia
- Prior art keywords
- age
- subject
- nyha
- troponin
- risk
- Prior art date
Links
- 238000013517 stratification Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 17
- 239000003550 marker Substances 0.000 claims abstract 11
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract 2
- 102000001554 Hemoglobins Human genes 0.000 claims abstract 2
- 108010054147 Hemoglobins Proteins 0.000 claims abstract 2
- 230000003907 kidney function Effects 0.000 claims abstract 2
- 230000035488 systolic blood pressure Effects 0.000 claims abstract 2
- 206010019280 Heart failures Diseases 0.000 claims 1
- 108020001621 Natriuretic Peptide Proteins 0.000 claims 1
- 102000004571 Natriuretic peptide Human genes 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 239000000692 natriuretic peptide Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 abstract 2
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 abstract 2
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 abstract 2
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261691706P | 2012-08-21 | 2012-08-21 | |
| US61/691,706 | 2012-08-21 | ||
| PCT/US2013/056020 WO2014031764A1 (en) | 2012-08-21 | 2013-08-21 | Multimarker risk stratification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015110054A true RU2015110054A (ru) | 2016-10-10 |
Family
ID=50148799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015110054A RU2015110054A (ru) | 2012-08-21 | 2013-08-21 | Мультимаркерная стратификация риска |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20140058743A1 (https=) |
| EP (1) | EP2888687B1 (https=) |
| JP (3) | JP6450679B2 (https=) |
| CN (2) | CN104737170A (https=) |
| AU (3) | AU2013305829A1 (https=) |
| CA (1) | CA2882303A1 (https=) |
| HK (2) | HK1208092A1 (https=) |
| IN (1) | IN2015DN01767A (https=) |
| MX (2) | MX375520B (https=) |
| RU (1) | RU2015110054A (https=) |
| SG (2) | SG10201608854TA (https=) |
| WO (1) | WO2014031764A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| DK3072978T3 (en) | 2002-05-09 | 2018-09-17 | Brigham & Womens Hospital Inc | : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER |
| AU2007244927B2 (en) | 2006-04-24 | 2012-01-12 | Critical Care Diagnostics, Inc. | Predicting mortality and detecting severe disease |
| EP2021796B1 (en) | 2006-05-01 | 2012-02-08 | Critical Care Diagnostics, Inc. | Diagnosis of cardiovascular disease |
| PL2269063T3 (pl) | 2008-04-18 | 2014-04-30 | Critical Care Diagnostics Inc | Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych |
| BR112012025728B1 (pt) | 2010-04-09 | 2022-01-11 | Critical Care Diagnostics, Inc | Anticorpos isolados ou fragmentos que se liga a st2 humano solúvel, hibridoma, kit, bem como métodos para quantificação de um nível de st2 solúvel humano em uma amostra de um indivíduo, e para a predição do risco de morte dentro de um ano em um indivíduo |
| ES2750126T3 (es) | 2011-03-17 | 2020-03-25 | Critical Care Diagnostics Inc | Procedimientos de predicción del riesgo de un resultado clínico adverso |
| DK2734222T3 (en) | 2011-07-18 | 2017-01-30 | Critical Care Diagnostics Inc | PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY |
| CA2873896A1 (en) | 2012-05-18 | 2013-11-21 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| MX382403B (es) | 2012-08-16 | 2025-03-13 | Critical Care Diagnostics Inc | Métodos para predecir el riesgo de desarrollar hipertensión. |
| CN104737170A (zh) | 2012-08-21 | 2015-06-24 | 重症监护诊断股份有限公司 | 多标记风险分层 |
| CA2935958A1 (en) * | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| WO2017035639A1 (en) | 2015-08-28 | 2017-03-09 | Mcmaster University | Method of determining risk of an adverse cardiac event |
| US20170220749A1 (en) * | 2016-02-01 | 2017-08-03 | MD Aware LLC | Systems and methods for identifying and using medical calculators |
| JP6983223B2 (ja) * | 2016-04-18 | 2021-12-17 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 一般集団におけるｌｖｈへの進行因子の同定のための可溶性ｓｔ２ |
| WO2018220600A1 (en) * | 2017-06-02 | 2018-12-06 | University Of Florida Research Foundation, Inc. | Method and apparatus for prediction of complications after surgery |
| RU2677611C1 (ru) * | 2018-04-16 | 2019-01-17 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ прогнозирования неблагоприятных сердечно-сосудистых событий в течение 12 месяцев у больных хронической сердечной недостаточностью с рецидивом стенокардии после реваскуляризации миокарда |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| EP3969620B1 (en) * | 2019-05-17 | 2025-06-25 | Regeneron Pharmaceuticals, Inc. | Genome-based methods for reducing cardiovascular risk |
| US20220399122A1 (en) * | 2019-11-01 | 2022-12-15 | Nec Corporation | Risk prediction apparatus, risk prediction method, and computer program |
| CN118760892B (zh) * | 2024-09-05 | 2024-11-19 | 温州市中心医院 | 铁死亡评分确定方法、系统及设备 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
| JPH0731479Y2 (ja) | 1989-06-02 | 1995-07-19 | 内橋エステック株式会社 | 温度ヒューズ |
| US5217899A (en) | 1990-08-24 | 1993-06-08 | The General Hospital Corporation | Cell stretching apparatus |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| JP2732005B2 (ja) | 1992-12-14 | 1998-03-25 | 眞一 富永 | ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法 |
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| CA2263832A1 (en) | 1996-08-23 | 1998-02-26 | Human Genome Sciences, Inc. | T1 receptor-like ligand ii |
| WO1998038311A1 (en) | 1997-02-28 | 1998-09-03 | Human Genome Sciences, Inc. | T1/st2-receptor ligand iii |
| ATE530180T1 (de) | 1997-04-02 | 2011-11-15 | Brigham & Womens Hospital | Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen |
| CA2293718A1 (en) | 1997-06-10 | 1998-12-17 | Medlyte Diagnostics, Inc. | Methods for early detection of heart disease |
| CN1161609C (zh) | 1997-09-11 | 2004-08-11 | 盐野义制药株式会社 | 哺乳类γ－BNP衍生物特异的免疫测定方法及其试剂盒 |
| US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
| GB9827348D0 (en) | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| AU2055300A (en) | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
| WO2000073498A1 (en) | 1999-06-02 | 2000-12-07 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
| FR2795823B1 (fr) | 1999-07-01 | 2001-11-23 | Inst Nat Sante Rech Med | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial |
| US6323334B1 (en) | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
| AU2001218871A1 (en) | 2000-03-21 | 2001-10-03 | Takao Arai | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same |
| FR2807170B1 (fr) | 2000-03-30 | 2002-06-28 | Sipal | Charniere elastique a frottement reduit |
| EP1311547A2 (en) | 2000-08-22 | 2003-05-21 | The Brigham And Women's Hospital, Inc. | Diagnosis and treatment of cardiovascular conditions |
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| US6537221B2 (en) | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
| FI20010019L (fi) | 2001-01-05 | 2002-07-06 | Biohit Oyj | Menetelmä atrofisen diagnostisoimiseksi |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| US20040253637A1 (en) | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| ATE458199T1 (de) | 2001-05-04 | 2010-03-15 | Biosite Inc | Diagnostische marker der akuten koronaren syndrome und ihre verwendungen |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| WO2003022987A2 (en) | 2001-07-26 | 2003-03-20 | Eos Biotechnology, Inc. | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection |
| US6810284B1 (en) | 2001-11-21 | 2004-10-26 | Pacesetter, Inc. | Implantable cardiac stimulation system and method for monitoring diastolic function |
| DK3072978T3 (en) | 2002-05-09 | 2018-09-17 | Brigham & Womens Hospital Inc | : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER |
| US8263325B2 (en) | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
| WO2004056868A2 (en) | 2002-12-19 | 2004-07-08 | Endocube Sas | Nf-hev compositions and methods of use |
| US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
| US20040220155A1 (en) | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
| US20050123451A1 (en) | 2003-10-31 | 2005-06-09 | Hiroshi Nomura | System and apparatus for body fluid analysis using surface-textured optical materials |
| CA2547072C (en) | 2003-11-26 | 2015-06-23 | Applera Corporation | Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
| EP2306192B1 (en) | 2003-12-05 | 2015-10-14 | The Cleveland Clinic Foundation | Risk Markers For Cardiovascular Disease |
| US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| JP2005291899A (ja) | 2004-03-31 | 2005-10-20 | Akira Matsumori | 心疾患の検査法 |
| EP1849009B1 (en) | 2005-01-24 | 2008-10-29 | F. Hoffmann-La Roche AG | The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs. |
| EP1731910A1 (en) | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| US20070021977A1 (en) | 2005-07-19 | 2007-01-25 | Witt Biomedical Corporation | Automated system for capturing and archiving information to verify medical necessity of performing medical procedure |
| JP4820192B2 (ja) | 2006-03-17 | 2011-11-24 | 一般財団法人化学及血清療法研究所 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
| AU2007244927B2 (en) | 2006-04-24 | 2012-01-12 | Critical Care Diagnostics, Inc. | Predicting mortality and detecting severe disease |
| ATE517341T1 (de) | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen |
| EP2021796B1 (en) * | 2006-05-01 | 2012-02-08 | Critical Care Diagnostics, Inc. | Diagnosis of cardiovascular disease |
| PL2019965T3 (pl) | 2006-05-02 | 2015-10-30 | Critical Care Diagnostics Inc | Rozpoznawanie różnicowe chorób układu oddechowego i sercowo-naczyniowego |
| US8147817B2 (en) | 2006-05-04 | 2012-04-03 | The Brigham And Women's Hospital, Inc. | IL-33 in the treatment and diagnosis of diseases and disorders |
| RU2312591C1 (ru) | 2006-06-14 | 2007-12-20 | Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" | Способ прогнозирования развития риска внезапной смерти у больных с лево- и правожелудочковой экстрасистолией |
| CA2554659A1 (en) * | 2006-07-25 | 2006-11-24 | 1128971 Alberta Ltd. | Hanger flange for hanging a tubular body in a well |
| US20080233191A1 (en) * | 2007-03-22 | 2008-09-25 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
| US20090111708A1 (en) * | 2007-05-11 | 2009-04-30 | Seddon Johanna M | Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| US20100267062A1 (en) * | 2007-09-26 | 2010-10-21 | Norbert Frey | Osteopontin as Novel Prognostic Biomarker for Heart Failure |
| FR2923029B1 (fr) | 2007-10-26 | 2009-11-20 | Minima | Lunettes de type sans entourage a branches filaires |
| WO2009075566A1 (en) * | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
| PL2269063T3 (pl) * | 2008-04-18 | 2014-04-30 | Critical Care Diagnostics Inc | Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych |
| US20100159474A1 (en) * | 2008-11-11 | 2010-06-24 | B.R.A.H.M.S. Aktiengesellschaft | Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp |
| JP2012531605A (ja) * | 2009-07-01 | 2012-12-10 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 心血管死亡率リスクを予測するための方法 |
| KR20120101064A (ko) * | 2009-11-13 | 2012-09-12 | 비쥐 메디신, 인코포레이티드 | 심근 경색의 위험 인자 및 예측 |
| US8258456B2 (en) * | 2009-11-27 | 2012-09-04 | Himax Imaging, Inc. | Image sensor |
| BR112012025728B1 (pt) | 2010-04-09 | 2022-01-11 | Critical Care Diagnostics, Inc | Anticorpos isolados ou fragmentos que se liga a st2 humano solúvel, hibridoma, kit, bem como métodos para quantificação de um nível de st2 solúvel humano em uma amostra de um indivíduo, e para a predição do risco de morte dentro de um ano em um indivíduo |
| WO2012059477A1 (en) * | 2010-11-01 | 2012-05-10 | B.R.A.H.M.S Gmbh | Prognosis and risk assessment of patients with non-specific complaints |
| RU2452394C1 (ru) | 2010-11-09 | 2012-06-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Ульяновский государственный университет | Способ прогнозирования риска смерти больных хронической сердечной недостаточностью |
| ES2750126T3 (es) | 2011-03-17 | 2020-03-25 | Critical Care Diagnostics Inc | Procedimientos de predicción del riesgo de un resultado clínico adverso |
| DK2734222T3 (en) | 2011-07-18 | 2017-01-30 | Critical Care Diagnostics Inc | PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY |
| CA2873896A1 (en) | 2012-05-18 | 2013-11-21 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| MX382403B (es) | 2012-08-16 | 2025-03-13 | Critical Care Diagnostics Inc | Métodos para predecir el riesgo de desarrollar hipertensión. |
| CN104737170A (zh) | 2012-08-21 | 2015-06-24 | 重症监护诊断股份有限公司 | 多标记风险分层 |
| JP6178687B2 (ja) | 2013-09-27 | 2017-08-09 | 富士機械工業株式会社 | グラビア塗工装置 |
| CA2935958A1 (en) | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| USD770057S1 (en) | 2014-04-14 | 2016-10-25 | Critical Care Diagnostics, Inc. | Blood test kit |
| US9934249B2 (en) | 2014-06-03 | 2018-04-03 | Conduent Business Machines Services, Llc | Systems and methods for context-aware and personalized access to visualizations of road events |
| USD800332S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| USD800333S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
-
2013
- 2013-08-21 CN CN201380054795.8A patent/CN104737170A/zh active Pending
- 2013-08-21 MX MX2015002254A patent/MX375520B/es active IP Right Grant
- 2013-08-21 RU RU2015110054A patent/RU2015110054A/ru not_active Application Discontinuation
- 2013-08-21 CN CN202010424423.1A patent/CN111834009A/zh active Pending
- 2013-08-21 IN IN1767DEN2015 patent/IN2015DN01767A/en unknown
- 2013-08-21 CA CA2882303A patent/CA2882303A1/en not_active Abandoned
- 2013-08-21 AU AU2013305829A patent/AU2013305829A1/en not_active Abandoned
- 2013-08-21 US US13/972,596 patent/US20140058743A1/en not_active Abandoned
- 2013-08-21 SG SG10201608854TA patent/SG10201608854TA/en unknown
- 2013-08-21 SG SG11201501271TA patent/SG11201501271TA/en unknown
- 2013-08-21 WO PCT/US2013/056020 patent/WO2014031764A1/en not_active Ceased
- 2013-08-21 EP EP13831501.5A patent/EP2888687B1/en active Active
- 2013-08-21 HK HK15108723.0A patent/HK1208092A1/xx unknown
- 2013-08-21 JP JP2015528625A patent/JP6450679B2/ja not_active Expired - Fee Related
- 2013-08-21 HK HK15112621.5A patent/HK1212057A1/xx unknown
-
2015
- 2015-02-20 MX MX2020009943A patent/MX2020009943A/es unknown
-
2016
- 2016-12-20 US US15/385,095 patent/US10303844B2/en active Active
-
2018
- 2018-12-10 JP JP2018230514A patent/JP6621520B2/ja not_active Expired - Fee Related
-
2019
- 2019-03-13 AU AU2019201709A patent/AU2019201709B2/en not_active Ceased
- 2019-04-10 US US16/380,513 patent/US10741290B2/en not_active Expired - Fee Related
- 2019-11-19 JP JP2019208375A patent/JP6902083B2/ja not_active Expired - Fee Related
-
2020
- 2020-07-07 US US16/922,580 patent/US20200335220A1/en not_active Abandoned
-
2021
- 2021-04-06 AU AU2021202116A patent/AU2021202116A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201501271TA (en) | 2015-03-30 |
| US10741290B2 (en) | 2020-08-11 |
| EP2888687B1 (en) | 2023-08-02 |
| HK1212057A1 (en) | 2016-06-03 |
| CN111834009A (zh) | 2020-10-27 |
| CN104737170A (zh) | 2015-06-24 |
| IN2015DN01767A (https=) | 2015-05-29 |
| JP2015532715A (ja) | 2015-11-12 |
| US20190237197A1 (en) | 2019-08-01 |
| JP6621520B2 (ja) | 2019-12-18 |
| CA2882303A1 (en) | 2014-02-27 |
| JP6450679B2 (ja) | 2019-01-09 |
| JP2020034573A (ja) | 2020-03-05 |
| AU2021202116A1 (en) | 2021-05-06 |
| AU2013305829A1 (en) | 2015-03-05 |
| US10303844B2 (en) | 2019-05-28 |
| JP6902083B2 (ja) | 2021-07-14 |
| MX375520B (es) | 2025-03-06 |
| AU2019201709A1 (en) | 2019-04-04 |
| HK1208092A1 (en) | 2016-02-19 |
| JP2019053086A (ja) | 2019-04-04 |
| MX2020009943A (es) | 2020-10-16 |
| EP2888687A1 (en) | 2015-07-01 |
| WO2014031764A1 (en) | 2014-02-27 |
| US20170169179A1 (en) | 2017-06-15 |
| US20140058743A1 (en) | 2014-02-27 |
| US20200335220A1 (en) | 2020-10-22 |
| EP2888687A4 (en) | 2016-04-13 |
| AU2019201709B2 (en) | 2021-01-07 |
| MX2015002254A (es) | 2015-05-08 |
| SG10201608854TA (en) | 2016-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015110054A (ru) | Мультимаркерная стратификация риска | |
| Jha et al. | Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation | |
| Turquetto et al. | Blunted peripheral blood supply and underdeveloped skeletal muscle in Fontan patients: the impact on functional capacity | |
| RU2014145259A (ru) | Прогнозирование нежелательных явлений у пациентов с предполагаемым диагнозом хронической сердечной недостаточности | |
| Koene et al. | HAS-BLED and CHA2DS2-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation | |
| Mikami et al. | Can we predict arterial lactate from venous lactate in the ED? | |
| Kilic et al. | Adult-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) risk score predicts short-term mortality after pediatric heart transplantation | |
| Knoedler et al. | Protein as a preoperative predictor–Impact of hypoalbuminemia on 30-day outcomes of breast reduction surgery | |
| Toledo‐Pons et al. | Obstructive sleep apnea is associated with worse clinical‐radiological risk scores of pulmonary embolism | |
| Barssoum et al. | Outcomes of cardiac arrest and cardiopulmonary resuscitation in patients with left ventricular assist device; an insight from a national inpatient sample | |
| CN113314225A (zh) | 一种术后风险预测模型的建立方法及装置 | |
| Cherbi et al. | Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry | |
| Shin et al. | Optimizing hemodialysis management using bioelectrical impedance analysis: emphasizing the significance of the phase angle | |
| RU2641843C2 (ru) | Способ прогнозирования риска смерти больных с острой декомпенсацией хронической сердечной недостаточности | |
| Korkmaz et al. | Hearts and minds: real-life cardiotoxicity with clozapine in psychosis | |
| Li et al. | Relationship between serum uric acid levels and patient conditions and prognosis in idiopathic pulmonary arterial hypertension | |
| Marra et al. | Stratifying pulmonary embolism risk in COVID-19 pneumonia in the Emergency Department: the BERPE-SCORE-Bergamo Emergency Room pulmonary embolism risk in COVID-19 score–a pilot study | |
| Bojko et al. | Fate of the preserved sinuses of Valsalva after emergency repair for acute type A aortic dissection | |
| JPWO2020201078A5 (https=) | ||
| Kapoor et al. | Hypotension is uncommon in patients presenting to the emergency department with non-traumatic cardiac tamponade | |
| Alonso-Martínez et al. | Inflammation in pulmonary embolism | |
| Zulkarnaev et al. | Vascular access in elderly patients on hemodialysis: balancing between local and systemic complications. Where is the compromise? | |
| You et al. | Interplay Between Serum Thyrotropin, Free Thyroxine, and Thyroid Autoantibody Levels and Survival in a Prospective Hemodialysis Cohort: PO1748 | |
| Cho et al. | Serum Cystatin C-to-Creatinine Ratio Is a Potential Biomarker for Sarcopenia in Patients with Non-Dialysis-Dependent CKD: PO1750 | |
| Prasad et al. | Assessing Left Ventricular Unloading and Wall Tension to Predict the Need for Durable Mechanical Circulatory Support after Peripheral VA-ECMO |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20190211 |